Renal denervation is a minimally invasive catheter-based procedure for the treatment of hypertension in patients. It is generally opted in cases where medicines fail to provide relief to the patient. In this procedure, nerves of the renal artery wall are ablated with the help of radiofrequency pulses or ultrasound. This leads to a reduction of sympathetic afferent and efferent kidney activity, which further leads to a reduction in blood pressure.
The world renal denervation market was $197 million in 2015 and is expected to reach $3,153 million by 2022 with a CAGR of 48.5%. The market is driven by factors such as changes in lifestyle of the people, which leads to uncontrolled, treatment resistant hypertension, and ageing population. In addition to this, technological advancements have helped in the development of innovative and efficient denervation devices that have driven the market growth. However, low awareness for renal denervation procedure, stringent regulatory norms for renal denervation systems, and unfavorable reimbursements for renal denervation procedure have restricted the growth of the market.
The report segments the market based on product, technology, and geography. Based on product, it is segmented into Symplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Paradise Renal Denervation System, and Iberis Renal Sympathetic Denervation System. Based on technology, the market is segmented into radiofrequency, ultrasound, and micro-infusion. Based on geography, the market is divided into four major regions, namely, North America (the U.S., Canada, and Mexico), Europe (Germany, France, U.K., Italy, and Spain), Asia-Pacific (Japan, China, India, Australia, and New Zealand), and LAMEA (Brazil, South Africa, and Saudi Arabia).
The market has witnessed product development and acquisitions in the recent years. These acquisitions have helped the major players to combine their forces with smaller players and enhance their business. In this regard, Boston Scientific Corporation acquired Vessix Vascular, Inc. (November 2012) and Medtonic plc acquired Ardian, Inc. (January 2011). Both Vessix Vascular, Inc. and Ardian, Inc. were the producers of renal denervation devices. However, due to smaller production capacities and limited geographical presence the systems were not popular in the market. However, after the acquisition these systems were produced on a large scale. This enabled Medtonic plc and Boston Scientific Corporation to emerge as the top leading companies for renal denervation devices.
Key players that operate in this market include Ablative Solutions, Inc., Boston Scientific Corporation, Cardiosonic Ltd, Kona Medical, Inc., Medtronic plc, Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, St. Jude Medical, Inc., and Terumo Medical Corporation.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
Positron-emission tomography (PET) is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on a biologically active molecule. Three-dimensional images of tracer concentration ...
January 2018 | $4880 |View Details>>
"A guidewire is a long and flexible spring that assists the introduction and placement of implantable medical devices into a patient's body. This reprot focuses on coronary guide wire and peripheral guide wire, used for cardiovascular diseases, peripheral artery disease (PAD), peripheral vascular diseases (PVDs), abdominal aortic aneurysms (AAA) and carotid ...
January 2018 | $4480 |View Details>>
In this report, the global Breast Surgery Retractor market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, ...
January 2018 | $2900 |View Details>>
In this report, the global Foley Catheters market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, ...
January 2018 | $2900 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2018 © Copyright Big Market Research